These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11220786)

  • 21. Metabolic changes in the knockout mouse for Canavan's disease: implications for patients with Canavan's disease.
    Surendran S; Matalon KM; Szucs S; Tyring SK; Matalon R
    J Child Neurol; 2003 Sep; 18(9):611-5. PubMed ID: 14572139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canavan disease: a monogenic trait with complex genomic interaction.
    Surendran S; Michals-Matalon K; Quast MJ; Tyring SK; Wei J; Ezell EL; Matalon R
    Mol Genet Metab; 2003; 80(1-2):74-80. PubMed ID: 14567959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.
    Moffett JR; Ross B; Arun P; Madhavarao CN; Namboodiri AM
    Prog Neurobiol; 2007 Feb; 81(2):89-131. PubMed ID: 17275978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease.
    Klugmann M; Leichtlein CB; Symes CW; Serikawa T; Young D; During MJ
    Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of NAA-synthesis in the human brain in vivo: Canavan's disease, Alzheimer's disease and schizophrenia.
    Harris K; Lin A; Bhattacharya P; Tran T; Wong W; Ross B
    Adv Exp Med Biol; 2006; 576():263-73; discussion 361-3. PubMed ID: 16802718
    [No Abstract]   [Full Text] [Related]  

  • 26. Brain N-acetylaspartate as a molecular water pump and its role in the etiology of Canavan disease: a mechanistic explanation.
    Baslow MH
    J Mol Neurosci; 2003; 21(3):185-90. PubMed ID: 14645985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical clinical and radiological course of a patient with Canavan disease.
    Sarret C; Boespflug-Tanguy O; Rodriguez D
    Metab Brain Dis; 2016 Apr; 31(2):475-9. PubMed ID: 26586007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canavan disease and the role of N-acetylaspartate in myelin synthesis.
    Namboodiri AM; Peethambaran A; Mathew R; Sambhu PA; Hershfield J; Moffett JR; Madhavarao CN
    Mol Cell Endocrinol; 2006 Jun; 252(1-2):216-23. PubMed ID: 16647192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astroglial conditional Slc13a3 knockout is therapeutic in murine Canavan leukodystrophy.
    Hull VL; Wang Y; McDonough J; Zhu M; Burns T; Al Ramel N; Dehghani A; Guo F; Pleasure D
    Ann Clin Transl Neurol; 2024 Apr; 11(4):1059-1062. PubMed ID: 38282243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes.
    Baslow MH; Suckow RF; Sapirstein V; Hungund BL
    J Mol Neurosci; 1999; 13(1-2):47-53. PubMed ID: 10691291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology and Treatment of Canavan Disease.
    Pleasure D; Guo F; Chechneva O; Bannerman P; McDonough J; Burns T; Wang Y; Hull V
    Neurochem Res; 2020 Mar; 45(3):561-565. PubMed ID: 30535831
    [No Abstract]   [Full Text] [Related]  

  • 32. Canavan's spongiform leukodystrophy (Aspartoacylase deficiency) with emphasis on sonographic features in infancy: description of a case report and review of the literature.
    Rossler L; Lemburg S; Weitkämper A; Thiels C; Hoffjan S; Nguyen HP; Lücke T; Heyer CM
    J Ultrasound; 2023 Dec; 26(4):757-764. PubMed ID: 35187608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review.
    Baslow MH
    Neurochem Int; 2002 Apr; 40(4):295-300. PubMed ID: 11792458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild-onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene.
    Janson CG; Kolodny EH; Zeng BJ; Raghavan S; Pastores G; Torres P; Assadi M; McPhee S; Goldfarb O; Saslow B; Freese A; Wang DJ; Bilaniuk L; Shera D; Leone P
    Ann Neurol; 2006 Feb; 59(2):428-31. PubMed ID: 16437572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging in juvenile Canavan disease.
    Toft PB; Geiss-Holtorff R; Rolland MO; Pryds O; Müller-Forell W; Christensen E; Lehnert W; Lou HC; Ott D; Hennig J
    Eur J Pediatr; 1993 Sep; 152(9):750-3. PubMed ID: 8223809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canavan disease: a white matter disorder.
    Kumar S; Mattan NS; de Vellis J
    Ment Retard Dev Disabil Res Rev; 2006; 12(2):157-65. PubMed ID: 16807907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary treatment proposed for Canavan's disease.
    Chen V
    Lancet Neurol; 2005 May; 4(5):273. PubMed ID: 15861552
    [No Abstract]   [Full Text] [Related]  

  • 38. Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease.
    Leone P; Janson CG; McPhee SJ; During MJ
    Curr Opin Mol Ther; 1999 Aug; 1(4):487-92. PubMed ID: 11713764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up after gene therapy for canavan disease.
    Leone P; Shera D; McPhee SW; Francis JS; Kolodny EH; Bilaniuk LT; Wang DJ; Assadi M; Goldfarb O; Goldman HW; Freese A; Young D; During MJ; Samulski RJ; Janson CG
    Sci Transl Med; 2012 Dec; 4(165):165ra163. PubMed ID: 23253610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Canavan disease or N-acetyl aspartic aciduria: a case report].
    Boughamoura L; Chaabane F; Tilouche S; Chabchoub I; Kabachi N; Tlili K; Yacoub M; Essoussi AS
    Arch Pediatr; 2007 Feb; 14(2):173-6. PubMed ID: 17196380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.